Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Pathol Res Pract ; 215(11): 152640, 2019 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-31570279

RESUMO

AIMS: Genomic instability has been indicated during the dedifferentiation process from leiomyoma (LM) to leiomyosarcoma (LMS). Previously, we have described that nuclear expression pattern of DNA damage response protein p53-binding protein 1 (53BP1), detected by immunofluorescence, reflects the magnitude of genomic instability during malignancy. Here, we present a case of LMS arising from LM with molecular analysis of 53BP1, which showed transitional magnitude of DNA damage response within a tumor. METHODS AND RESULTS: A fifty-year-old female with abdominal mass underwent hysterectomy. Histologically, the tumor consisted of LMS with highly atypical multinucleated giant cells as well as an LM component with transitional atypical spindle cells in the border area. LMS showed diffuse nuclear staining of 53BP1 expression, which has been previously described as high DNA damage response pattern. In contrast, the LM component lacked 53BP1 immunoreactivity and focal expression was observed in transitional lesion. Furthermore, double-labelled immunofluorescence revealed co-localization of 53BP1 with p53 and Ki-67 in the LMS component, which indicated abnormal DNA damage response in proliferative state. CONCLUSIONS: This study revealed that diffuse-type 53BP1 expression may be beneficial to estimate genomic instability during dedifferentiation from LM to DLMS.


Assuntos
Leiomioma/patologia , Leiomiossarcoma/patologia , Neoplasias Primárias Múltiplas/patologia , Proteína 1 de Ligação à Proteína Supressora de Tumor p53/análise , Neoplasias Uterinas/patologia , Desdiferenciação Celular/genética , Transformação Celular Neoplásica/genética , Feminino , Imunofluorescência , Instabilidade Genômica/genética , Humanos , Leiomiossarcoma/genética , Pessoa de Meia-Idade , Neoplasias Primárias Múltiplas/genética , Neoplasias Uterinas/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...